[DPHARMA] YoY Cumulative Quarter Result on 30-Jun-2011 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-Aug-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Jun-2011 [#2]
Profit Trend
QoQ- 117.02%
YoY- 3.38%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Revenue 81,118 75,826 70,412 68,329 64,777 61,728 60,977 4.86%
PBT 21,302 21,963 17,906 17,166 16,582 20,337 20,630 0.53%
Tax -5,410 -4,575 -4,331 -4,310 -4,146 -4,877 -5,339 0.22%
NP 15,892 17,388 13,575 12,856 12,436 15,460 15,291 0.64%
-
NP to SH 15,892 17,388 13,575 12,856 12,436 15,460 15,291 0.64%
-
Tax Rate 25.40% 20.83% 24.19% 25.11% 25.00% 23.98% 25.88% -
Total Cost 65,226 58,438 56,837 55,473 52,341 46,268 45,686 6.11%
-
Net Worth 179,045 187,340 162,400 154,105 140,182 136,003 129,043 5.60%
Dividend
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Div 5,551 5,550 4,858 4,859 6,245 83 11,100 -10.90%
Div Payout % 34.93% 31.92% 35.79% 37.80% 50.22% 0.54% 72.60% -
Equity
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Net Worth 179,045 187,340 162,400 154,105 140,182 136,003 129,043 5.60%
NOSH 138,794 138,770 138,803 138,833 138,794 138,779 138,756 0.00%
Ratio Analysis
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
NP Margin 19.59% 22.93% 19.28% 18.81% 19.20% 25.05% 25.08% -
ROE 8.88% 9.28% 8.36% 8.34% 8.87% 11.37% 11.85% -
Per Share
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
RPS 58.44 54.64 50.73 49.22 46.67 44.48 43.95 4.86%
EPS 11.45 12.53 9.78 9.26 8.96 11.14 11.02 0.63%
DPS 4.00 4.00 3.50 3.50 4.50 0.06 8.00 -10.90%
NAPS 1.29 1.35 1.17 1.11 1.01 0.98 0.93 5.60%
Adjusted Per Share Value based on latest NOSH - 138,917
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
RPS 8.43 7.88 7.31 7.10 6.73 6.41 6.33 4.88%
EPS 1.65 1.81 1.41 1.34 1.29 1.61 1.59 0.61%
DPS 0.58 0.58 0.50 0.50 0.65 0.01 1.15 -10.77%
NAPS 0.186 0.1946 0.1687 0.1601 0.1456 0.1413 0.1341 5.60%
Price Multiplier on Financial Quarter End Date
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Date 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 30/06/08 -
Price 2.97 2.38 2.23 2.34 2.45 2.13 2.48 -
P/RPS 5.08 4.36 4.40 4.75 5.25 4.79 5.64 -1.72%
P/EPS 25.94 18.99 22.80 25.27 27.34 19.12 22.50 2.39%
EY 3.86 5.26 4.39 3.96 3.66 5.23 4.44 -2.30%
DY 1.35 1.68 1.57 1.50 1.84 0.03 3.23 -13.52%
P/NAPS 2.30 1.76 1.91 2.11 2.43 2.17 2.67 -2.45%
Price Multiplier on Announcement Date
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Date 26/08/14 28/08/13 16/08/12 18/08/11 24/08/10 26/08/09 26/08/08 -
Price 3.37 2.44 2.38 2.22 2.45 2.50 2.30 -
P/RPS 5.77 4.47 4.69 4.51 5.25 5.62 5.23 1.65%
P/EPS 29.43 19.47 24.34 23.97 27.34 22.44 20.87 5.89%
EY 3.40 5.14 4.11 4.17 3.66 4.46 4.79 -5.55%
DY 1.19 1.64 1.47 1.58 1.84 0.02 3.48 -16.36%
P/NAPS 2.61 1.81 2.03 2.00 2.43 2.55 2.47 0.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment